Journal
CANCER CELL
Volume 2, Issue 1, Pages 43-54Publisher
CELL PRESS
DOI: 10.1016/S1535-6108(02)00084-3
Keywords
-
Categories
Funding
- NCI NIH HHS [CA90917, CA78810] Funding Source: Medline
- NHLBI NIH HHS [HL54131] Funding Source: Medline
Ask authors/readers for more resources
A checkpoint surveying the entry into mitosis responds to defects in spindle microtubule assembly/stability. This has been used to trigger apoptosis in cancer cells, but how the spindle checkpoint couples to the cell survival machinery has remained elusive. Here, we report that microtubule stabilization engenders a survival pathway that depends on elevated activity of p34(cdc2) kinase and increased expression of the apoptosis inhibitor and mitotic regulator, survivin. Pharmacologic, genetic, or molecular ablation of p34(cdc2) kinase after microtubule stabilization resulted in massive apoptosis independent of p53, suppression of tumor growth, and indefinite survival without toxicity in mice. By ablating this survival checkpoint, inhibitors of p34(cdc2) kinase could safely improve the efficacy of microtubule-stabilizing agents used to treat common cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available